AUPR491901A0 - Cancer diagnosis and therapy - Google Patents

Cancer diagnosis and therapy

Info

Publication number
AUPR491901A0
AUPR491901A0 AUPR4919A AUPR491901A AUPR491901A0 AU PR491901 A0 AUPR491901 A0 AU PR491901A0 AU PR4919 A AUPR4919 A AU PR4919A AU PR491901 A AUPR491901 A AU PR491901A AU PR491901 A0 AUPR491901 A0 AU PR491901A0
Authority
AU
Australia
Prior art keywords
therapy
cancer diagnosis
diagnosis
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPR4919A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Queensland University of Technology QUT
Original Assignee
University of Queensland UQ
Queensland University of Technology QUT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Queensland UQ, Queensland University of Technology QUT filed Critical University of Queensland UQ
Priority to AUPR4919A priority Critical patent/AUPR491901A0/en
Publication of AUPR491901A0 publication Critical patent/AUPR491901A0/en
Priority to EP02724043A priority patent/EP1385879A4/en
Priority to US10/477,506 priority patent/US20040157227A1/en
Priority to AU2002254800A priority patent/AU2002254800B2/en
Priority to PCT/AU2002/000582 priority patent/WO2002090387A1/en
Priority to CA002446857A priority patent/CA2446857A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Cell Biology (AREA)
AUPR4919A 2001-05-10 2001-05-10 Cancer diagnosis and therapy Abandoned AUPR491901A0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AUPR4919A AUPR491901A0 (en) 2001-05-10 2001-05-10 Cancer diagnosis and therapy
EP02724043A EP1385879A4 (en) 2001-05-10 2002-05-10 Reproductive cancer diagnosis and therapy
US10/477,506 US20040157227A1 (en) 2001-05-10 2002-05-10 Reproductive cancer diagnosis and therapy
AU2002254800A AU2002254800B2 (en) 2001-05-10 2002-05-10 Reproductive cancer diagnosis and therapy
PCT/AU2002/000582 WO2002090387A1 (en) 2001-05-10 2002-05-10 Reproductive cancer diagnosis and therapy
CA002446857A CA2446857A1 (en) 2001-05-10 2002-05-10 Reproductive cancer diagnosis and therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPR4919A AUPR491901A0 (en) 2001-05-10 2001-05-10 Cancer diagnosis and therapy

Publications (1)

Publication Number Publication Date
AUPR491901A0 true AUPR491901A0 (en) 2001-06-07

Family

ID=3828906

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPR4919A Abandoned AUPR491901A0 (en) 2001-05-10 2001-05-10 Cancer diagnosis and therapy

Country Status (1)

Country Link
AU (1) AUPR491901A0 (en)

Similar Documents

Publication Publication Date Title
AU2002251844A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001268259A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001269766A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AUPS054702A0 (en) Cancer therapy
EP1587837A3 (en) Prostate cancer diagnosis and treatment
AU2002254482A1 (en) Compositions and methods for the therapy and diagnosis of kidney cancer
AU2001280982A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002319338A1 (en) Cancer specific oligosaccharide sequences and use thereof
AU2002303219A1 (en) Compositions and methods for the therapy and diagnosis of cancer
AU2002246519A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002258728A1 (en) Gene brcc-3 and diagnostic and therapeutic uses thereof
AU2002305151A1 (en) Gene scc-112 and diagnostic and therapeutic uses thereof
AU2002303261A1 (en) Gene brcc2 and diagnostic and therapeutic uses thereof
AU2002342053A1 (en) Pancreatic cancer diagnosis and therapies
AU2001290518A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
EP1385879A4 (en) Reproductive cancer diagnosis and therapy
AU2002335667A1 (en) Modified reoviral therapy
AU2002330724A1 (en) Diagnosis, prevention and treatment of cancer
GB0326578D0 (en) Cancer diagnosis and therapy
AU2002346049A1 (en) Coactivators in the diagnosis and treatment of breast cancer
AU2002366195A1 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer
AU2001266790A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001257325A1 (en) Cancer treatment
AU2002332606A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002351382A1 (en) Combination cancer therapy